210 related articles for article (PubMed ID: 30177233)
1. Inhibition of prolyl hydroxylases alters cell metabolism and reverses pre-existing diastolic dysfunction in mice.
He X; Zeng H; Roman RJ; Chen JX
Int J Cardiol; 2018 Dec; 272():281-287. PubMed ID: 30177233
[TBL] [Abstract][Full Text] [Related]
2. Systemic hypoxia mimicry enhances axonal regeneration and functional recovery following peripheral nerve injury.
Smaila BD; Holland SD; Babaeijandaghi F; Henderson HG; Rossi FMV; Ramer MS
Exp Neurol; 2020 Dec; 334():113436. PubMed ID: 32814068
[TBL] [Abstract][Full Text] [Related]
3. DMOG, a Prolyl Hydroxylase Inhibitor, Increases Hemoglobin Levels without Exacerbating Hypertension and Renal Injury in Salt-Sensitive Hypertensive Rats.
Kato S; Takahashi T; Miyata N; Roman RJ
J Pharmacol Exp Ther; 2020 Feb; 372(2):166-174. PubMed ID: 31801803
[TBL] [Abstract][Full Text] [Related]
4. Endothelial specific SIRT3 deletion impairs glycolysis and angiogenesis and causes diastolic dysfunction.
He X; Zeng H; Chen ST; Roman RJ; Aschner JL; Didion S; Chen JX
J Mol Cell Cardiol; 2017 Nov; 112():104-113. PubMed ID: 28935506
[TBL] [Abstract][Full Text] [Related]
5. Prolyl-hydroxylase inhibition induces SDF-1 associated with increased CXCR4+/CD11b+ subpopulations and cardiac repair.
Ghadge SK; Messner M; Van Pham T; Doppelhammer M; Petry A; Görlach A; Husse B; Franz WM; Zaruba MM
J Mol Med (Berl); 2017 Aug; 95(8):825-837. PubMed ID: 28550361
[TBL] [Abstract][Full Text] [Related]
6. Sestrin2 inhibits hypoxia-inducible factor-1α accumulation via AMPK-mediated prolyl hydroxylase regulation.
Seo K; Seo S; Ki SH; Shin SM
Free Radic Biol Med; 2016 Dec; 101():511-523. PubMed ID: 27840318
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-inducible factor prolyl 4-hydroxylase inhibition in cardiometabolic diseases.
Koivunen P; Serpi R; Dimova EY
Pharmacol Res; 2016 Dec; 114():265-273. PubMed ID: 27832958
[TBL] [Abstract][Full Text] [Related]
8. The prolyl 4-hydroxylase inhibitor GSK360A decreases post-stroke brain injury and sensory, motor, and cognitive behavioral deficits.
Zhou J; Li J; Rosenbaum DM; Zhuang J; Poon C; Qin P; Rivera K; Lepore J; Willette RN; Hu E; Barone FC
PLoS One; 2017; 12(9):e0184049. PubMed ID: 28880966
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia inhibits TNF-α-induced TSLP expression in keratinocytes.
Tashiro N; Segawa R; Tobita R; Asakawa S; Mizuno N; Hiratsuka M; Hirasawa N
PLoS One; 2019; 14(11):e0224705. PubMed ID: 31682627
[TBL] [Abstract][Full Text] [Related]
10. Recent Advances in Developing Inhibitors for Hypoxia-Inducible Factor Prolyl Hydroxylases and Their Therapeutic Implications.
Kim SY; Yang EG
Molecules; 2015 Nov; 20(11):20551-68. PubMed ID: 26610437
[TBL] [Abstract][Full Text] [Related]
11. Prolyl-hydroxylase inhibition preserves endothelial cell function in a rat model of vascular ischemia reperfusion injury.
Barnucz E; Veres G; Hegedűs P; Klein S; Zöller R; Radovits T; Korkmaz S; Horkay F; Merkely B; Karck M; Szabó G
J Pharmacol Exp Ther; 2013 Apr; 345(1):25-31. PubMed ID: 23388095
[TBL] [Abstract][Full Text] [Related]
12. The Prolyl Hydroxylase Inhibitor Dimethyl Oxalyl Glycine Decreases Early Gastrointestinal GVHD in Experimental Allogeneic Hematopoietic Cell Transplantation.
Palaniyandi S; Kumari R; Venniyil Radhakrishnan S; Strattan E; Hakim N; Munker R; Kesler MV; Hildebrandt GC
Transplantation; 2020 Dec; 104(12):2507-2515. PubMed ID: 32639407
[TBL] [Abstract][Full Text] [Related]
13. HIF-1α activation results in actin cytoskeleton reorganization and modulation of Rac-1 signaling in endothelial cells.
Weidemann A; Breyer J; Rehm M; Eckardt KU; Daniel C; Cicha I; Giehl K; Goppelt-Struebe M
Cell Commun Signal; 2013 Oct; 11():80. PubMed ID: 24144209
[TBL] [Abstract][Full Text] [Related]
14. Endurance training prevents negative effects of the hypoxia mimetic dimethyloxalylglycine on cardiac and skeletal muscle function.
Favier FB; Britto FA; Ponçon B; Begue G; Chabi B; Reboul C; Meyer G; Py G
J Appl Physiol (1985); 2016 Feb; 120(4):455-63. PubMed ID: 26679609
[TBL] [Abstract][Full Text] [Related]
15. Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes.
Stoehr A; Yang Y; Patel S; Evangelista AM; Aponte A; Wang G; Liu P; Boylston J; Kloner PH; Lin Y; Gucek M; Zhu J; Murphy E
Cardiovasc Res; 2016 Jun; 110(3):346-58. PubMed ID: 27095734
[TBL] [Abstract][Full Text] [Related]
16. The role of HIF in cobalt-induced ischemic tolerance.
Jones SM; Novak AE; Elliott JP
Neuroscience; 2013 Nov; 252():420-30. PubMed ID: 23916558
[TBL] [Abstract][Full Text] [Related]
17. Dynamics of Prolyl Hydroxylases Levels During Disease Progression in Experimental Colitis.
Bakshi HA; Mishra V; Satija S; Mehta M; Hakkim FL; Kesharwani P; Dua K; Chellappan DK; Charbe NB; Shrivastava G; Rajeshkumar S; Aljabali AA; Al-Trad B; Pabreja K; Tambuwala MM
Inflammation; 2019 Dec; 42(6):2032-2036. PubMed ID: 31377947
[TBL] [Abstract][Full Text] [Related]
18. Effects of prolyl-hydroxylase inhibition and chronic intermittent hypoxia on synaptic transmission and plasticity in the rat CA1 and dentate gyrus.
Wall AM; Corcoran AE; O'Halloran KD; O'Connor JJ
Neurobiol Dis; 2014 Feb; 62():8-17. PubMed ID: 24055213
[TBL] [Abstract][Full Text] [Related]
19. Prolyl Hydroxylase Inhibitors: a New Opportunity in Renal and Myocardial Protection.
Requena-Ibáñez JA; Santos-Gallego CG; Rodriguez-Cordero A; Zafar MU; Badimon JJ
Cardiovasc Drugs Ther; 2022 Dec; 36(6):1187-1196. PubMed ID: 34533692
[TBL] [Abstract][Full Text] [Related]
20. High Glucose Activates Prolyl Hydroxylases and Disrupts HIF-α Signaling via the P53/TIGAR Pathway in Cardiomyocyte.
Chen JX; Li L; Cantrell AC; Williams QA; Zeng H
Cells; 2023 Mar; 12(7):. PubMed ID: 37048134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
